SaxoCellutions aims to engage you as scientists and founders with a variety of groups of interests like students, investors or even the broad public to exchange your topics on different levels. This gives you several opportunities to show your work and ideas in exchange for questions which you would never ask yourself.
Talk Science to Start-up and expand your knowledge and network on multidisciplinary formats like FameLab, FuckUpNight (see SaxoCell events) or TEDx. Contact us if you are ready to conquer stages outside your institute and join us in the journey of science communication.

Another fabulous way to talk science can be the production of a whole podcast series, as our SaxoCell PI Prof. Rüdiger managed in the last years.

(Feb 2025) Malignant T-cell transformation after chimeric antigen receptor (CAR) T-cell therapy has been described, but the contribution of CAR integration to oncogenesis is not clear. Here we report a case of a T-cell lymphoma harboring a lentiviral integration in a known tumor suppressor, TP53, which developed in a patient with multiple myeloma after B-cell maturation antigen (BCMA) CAR T-cell therapy.

SaxoCell Cluster consortium meeting in Januay in Leipzig
We had an inspiring and productive meeting to kick off the next phase of our SaxoCell project. Our project teams presented their exciting ideas and plans for the next three years - thank you for your active participation! A further highlight of the meeting was the participation of Projektträger Jülich (PtJ), who offered us valuable insights and support for further implementation of the projects.
A creative Lego Serious Play® workshop, run by MIKOMI from Hochschule Mittweida, helped us to develop innovative solutions and building our cluster in an unexpected way.
The inspiring keynote lecture by Prof. Andreas Zaby from SPRIND - Bundesagentur für Sprunginnovationen gave us new perspectives on groundbreaking innovations.

We are excited about the possibilities that lie ahead and look forward to shaping the future of cell and gene therapy together!
 

The highly informative sessions were spiced up by powerful talks of experienced guest speakers like Moritz Middeke (Cancilico), Luke Buchanan (Hertin), Stefanie Funke (TTO ULEI), Andreas Pinkwart (TUD excite) and of course Ingo Schroeter passionately guiding us through an insightful time.

The DG-GT theme day Genome editing towards therapies took place mid March in the amazing Hygiene-Museum of Dresden, where aout 150 participants from science and industry came together to discuss the latest developments and perspectives in gene therapy. The event, organized by the Buchholz Lab, impressively demonstrated how important the dialogue between research and industry is for progress in precision medical technology. After the opening by Frank Buchholz and Zoltan Ivics, participants could expect a varied program.  Boris Fehse, Sandy Tretbar, Ulrike Köhl, Toni Cathomen, Zoltan Ivics, Frank Buchholz chaired the sessions with international top-class speakers.
The highlights included the inspiring keynote by Toni Cathomen (University of Freiburg), and the vivid discussion on Ethics with students from MANOS, which offered exciting insights into current advances and challenges in gene therapies.

A big thank you goes to the team of Frank Buchholz, esp. Ira Illgen and Mandy Erlitz, for the first-class organization. The event was a complete success and we are looking forward to continuing this important dialogue. The DG-GT regularly brings together experts of gene therapy to discuss key issues ad further development. With a focus on current challenges and innovations, the forum offers a platform for interdisciplinary exchange and international networking.

If you are interested in more information about any of these events or about the role of SaxoCell at these conferences, please do not hesitate to contact us.